Vofatamab (B-701) is a monoclonal antibody that selectively targets the fibroblast growth factor receptor 3 (FGFR3). It effectively inhibits the activation of both the wild-type and mutant forms of this receptor. This antibody is particularly useful in research focused on metastatic urothelial carcinoma (mUC), providing a critical tool for investigating the role of FGFR3 in cancer progression and potential therapeutic interventions.
Vofatamab (B-701) is a monoclonal antibody that selectively targets the fibroblast growth factor receptor 3 (FGFR3). It effectively inhibits the activation of both the wild-type and mutant forms of this receptor. This antibody is particularly useful in research focused on metastatic urothelial carcinoma (mUC), providing a critical tool for investigating the role of FGFR3 in cancer progression and potential therapeutic interventions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
